<DOC>
	<DOCNO>NCT03071172</DOCNO>
	<brief_summary>The aim study evaluate efficacy safety domestic recombinant human follicle stimulate hormone ( rhFSH ) stimulate ovarian promote follicular development assist reproductive technology , non-inferiority import rhFSH .</brief_summary>
	<brief_title>Clinical Study Recombinant Human Follitropin Injection Assisted COH Assisted IVF-ET</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<criteria>Age 20 year old less 39 year old , married . Applicable ART control ovarian hyperstimulation , IVF/ET , ICSI , GIFT , ZIFT . Regular menstrual cycle ( 2535 day ) . 18kg/m2≤BMI＜30kg/m2 . The level basic serum FSH &lt; 10IU / L 2nd5th day menstrual cycle , luteinizing hormone , estradiol progesterone level normal . The screening period recent three month vaginal ultrasound examination show shape bilateral ovarian uterine size normal 5 ≤ number basal antral follicle unilateral ovarian &lt; 10 , follicular diameter &lt; 10 mm . The vitro fertilization embryo transfer ( IVF/ET ) ( ) intracytoplasmic sperm injection ( ICSI ) technology less three time use prior reproductive treatment ( provide copy previous case ) . Volunteer participate sign informed consent . There high risk ovarian hyperstimulation syndrome ( OHSS ) , subject high response gonadotropin previous ovarian hyperstimulation cycle , polycystic ovary syndrome ( PCOS ) , subject severe OHSS cancellation cycle . Affect outcome pregnancyrelated disease ( one ) : untreated hydrosalpinx , untreated uterine polyp , untreated uterine infection , stage Ⅲ ~ IV endometriosis , ovarian cyst &gt; 4cm , uterine fibroid diameter &gt; 4cm , pelvic benign tumor &gt; 4cm , pituitary tumor malignant tumor tissue organ . The subject abnormal uterine bleeding . Affect pregnancyrelated endocrine metabolic disease ( one ) : hyperprolactinemia , thyroid disease ( include hyperthyroidism , hypothyroidism ) , hyperandrogenism , adrenal dysfunction ( include adrenal hyperfunction , adrenal cortical dysfunction ) . The subject severe liver kidney dysfunction , level serum alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) 2.5 time high upper limit normal value , serum creatinine ( Cr ) urea nitrogen ( BUN ) 2 time high upper limit normal value . Severe heart disease , unstable angina pectoris , heart failure grade Ⅲ , acute myocardial infarction and/or old myocardial infarction , hypertension diagnose accord 2010 edition Chinese Hypertension Prevention Guidelines . The subject contraindication allergic history gonadotropinreleasing hormone agonist ( GnRHa ) , rFSH/human menopausal gonadotropin ( hMG ) , human chorionic gonadotropin ( hCG ) , progesterone drug . Positive HIV syphilis . The subject alcoholism , smoking , drug abuse , bad drug abuse habit . At least one spouses receive sperm donor egg donor PGD ( genetic diagnosis embryo transfer ) PGS ( Preimplantation embryos genetic screening ) 。 The subject receive clomiphene gonadotropin therapy within 1 month screening。 The subject participate last three month participate clinical research。 Patients positive serum pregnancy test . The investigator consider subject inappropriate enrol study .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>